The allosteric vestibule of a seven transmembrane helical receptor controls G-protein coupling. 2012

Andreas Bock, and Nicole Merten, and Ramona Schrage, and Clelia Dallanoce, and Julia Bätz, and Jessica Klöckner, and Jens Schmitz, and Carlo Matera, and Katharina Simon, and Anna Kebig, and Lucas Peters, and Anke Müller, and Jasmin Schrobang-Ley, and Christian Tränkle, and Carsten Hoffmann, and Marco De Amici, and Ulrike Holzgrabe, and Evi Kostenis, and Klaus Mohr
Pharmacology and Toxicology Section, Institute of Pharmacy, University of Bonn, Gerhard-Domagk-Straße 3, 53121 Bonn, Germany.

Seven transmembrane helical receptors (7TMRs) modulate cell function via different types of G proteins, often in a ligand-specific manner. Class A 7TMRs harbour allosteric vestibules in the entrance of their ligand-binding cavities, which are in the focus of current drug discovery. However, their biological function remains enigmatic. Here we present a new strategy for probing and manipulating conformational transitions in the allosteric vestibule of label-free 7TMRs using the M(2) acetylcholine receptor as a paradigm. We designed dualsteric agonists as 'tailor-made' chemical probes to trigger graded receptor activation from the acetylcholine-binding site while simultaneously restricting spatial flexibility of the receptor's allosteric vestibule. Our findings reveal for the first time that a 7TMR's allosteric vestibule controls the extent of receptor movement to govern a hierarchical order of G-protein coupling. This is a new concept assigning a biological role to the allosteric vestibule for controlling fidelity of 7TMR signalling.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000495 Allosteric Site A site on an enzyme which upon binding of a modulator, causes the enzyme to undergo a conformational change that may alter its catalytic or binding properties. Allosteric Sites,Site, Allosteric,Sites, Allosteric
D017433 Protein Structure, Secondary The level of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to ALPHA-HELICES; BETA-STRANDS (which align to form BETA-SHEETS), or other types of coils. This is the first folding level of protein conformation. Secondary Protein Structure,Protein Structures, Secondary,Secondary Protein Structures,Structure, Secondary Protein,Structures, Secondary Protein
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures
D043562 Receptors, G-Protein-Coupled The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS. G Protein Coupled Receptor,G-Protein-Coupled Receptor,G-Protein-Coupled Receptors,G Protein Coupled Receptors,Receptor, G-Protein-Coupled,Receptors, G Protein Coupled
D043585 Receptor, Muscarinic M2 A specific subtype of muscarinic receptor found in the lower BRAIN, the HEART and in SMOOTH MUSCLE-containing organs. Although present in smooth muscle the M2 muscarinic receptor appears not to be involved in contractile responses. Muscarinic Receptor M2,Muscarinic Receptors M2,Receptors, Muscarinic M2,M2 Receptor, Muscarinic,M2 Receptors, Muscarinic,M2, Muscarinic Receptor,M2, Muscarinic Receptors,Muscarinic M2 Receptor,Muscarinic M2 Receptors,Receptor M2, Muscarinic,Receptors M2, Muscarinic
D019204 GTP-Binding Proteins Regulatory proteins that act as molecular switches. They control a wide range of biological processes including: receptor signaling, intracellular signal transduction pathways, and protein synthesis. Their activity is regulated by factors that control their ability to bind to and hydrolyze GTP to GDP. EC 3.6.1.-. G-Proteins,GTP-Regulatory Proteins,Guanine Nucleotide Regulatory Proteins,G-Protein,GTP-Binding Protein,GTP-Regulatory Protein,Guanine Nucleotide Coupling Protein,G Protein,G Proteins,GTP Binding Protein,GTP Binding Proteins,GTP Regulatory Protein,GTP Regulatory Proteins,Protein, GTP-Binding,Protein, GTP-Regulatory,Proteins, GTP-Binding,Proteins, GTP-Regulatory

Related Publications

Andreas Bock, and Nicole Merten, and Ramona Schrage, and Clelia Dallanoce, and Julia Bätz, and Jessica Klöckner, and Jens Schmitz, and Carlo Matera, and Katharina Simon, and Anna Kebig, and Lucas Peters, and Anke Müller, and Jasmin Schrobang-Ley, and Christian Tränkle, and Carsten Hoffmann, and Marco De Amici, and Ulrike Holzgrabe, and Evi Kostenis, and Klaus Mohr
October 2020, ACS pharmacology & translational science,
Andreas Bock, and Nicole Merten, and Ramona Schrage, and Clelia Dallanoce, and Julia Bätz, and Jessica Klöckner, and Jens Schmitz, and Carlo Matera, and Katharina Simon, and Anna Kebig, and Lucas Peters, and Anke Müller, and Jasmin Schrobang-Ley, and Christian Tränkle, and Carsten Hoffmann, and Marco De Amici, and Ulrike Holzgrabe, and Evi Kostenis, and Klaus Mohr
August 2015, Molecular pharmacology,
Andreas Bock, and Nicole Merten, and Ramona Schrage, and Clelia Dallanoce, and Julia Bätz, and Jessica Klöckner, and Jens Schmitz, and Carlo Matera, and Katharina Simon, and Anna Kebig, and Lucas Peters, and Anke Müller, and Jasmin Schrobang-Ley, and Christian Tränkle, and Carsten Hoffmann, and Marco De Amici, and Ulrike Holzgrabe, and Evi Kostenis, and Klaus Mohr
September 2003, Journal of pharmacological sciences,
Andreas Bock, and Nicole Merten, and Ramona Schrage, and Clelia Dallanoce, and Julia Bätz, and Jessica Klöckner, and Jens Schmitz, and Carlo Matera, and Katharina Simon, and Anna Kebig, and Lucas Peters, and Anke Müller, and Jasmin Schrobang-Ley, and Christian Tränkle, and Carsten Hoffmann, and Marco De Amici, and Ulrike Holzgrabe, and Evi Kostenis, and Klaus Mohr
February 2010, Eukaryotic cell,
Andreas Bock, and Nicole Merten, and Ramona Schrage, and Clelia Dallanoce, and Julia Bätz, and Jessica Klöckner, and Jens Schmitz, and Carlo Matera, and Katharina Simon, and Anna Kebig, and Lucas Peters, and Anke Müller, and Jasmin Schrobang-Ley, and Christian Tränkle, and Carsten Hoffmann, and Marco De Amici, and Ulrike Holzgrabe, and Evi Kostenis, and Klaus Mohr
January 2010, Journal of receptor, ligand and channel research,
Andreas Bock, and Nicole Merten, and Ramona Schrage, and Clelia Dallanoce, and Julia Bätz, and Jessica Klöckner, and Jens Schmitz, and Carlo Matera, and Katharina Simon, and Anna Kebig, and Lucas Peters, and Anke Müller, and Jasmin Schrobang-Ley, and Christian Tränkle, and Carsten Hoffmann, and Marco De Amici, and Ulrike Holzgrabe, and Evi Kostenis, and Klaus Mohr
January 2013, Molecular metabolism,
Andreas Bock, and Nicole Merten, and Ramona Schrage, and Clelia Dallanoce, and Julia Bätz, and Jessica Klöckner, and Jens Schmitz, and Carlo Matera, and Katharina Simon, and Anna Kebig, and Lucas Peters, and Anke Müller, and Jasmin Schrobang-Ley, and Christian Tränkle, and Carsten Hoffmann, and Marco De Amici, and Ulrike Holzgrabe, and Evi Kostenis, and Klaus Mohr
August 2014, Journal of the American Chemical Society,
Andreas Bock, and Nicole Merten, and Ramona Schrage, and Clelia Dallanoce, and Julia Bätz, and Jessica Klöckner, and Jens Schmitz, and Carlo Matera, and Katharina Simon, and Anna Kebig, and Lucas Peters, and Anke Müller, and Jasmin Schrobang-Ley, and Christian Tränkle, and Carsten Hoffmann, and Marco De Amici, and Ulrike Holzgrabe, and Evi Kostenis, and Klaus Mohr
January 1996, Comptes rendus des seances de la Societe de biologie et de ses filiales,
Andreas Bock, and Nicole Merten, and Ramona Schrage, and Clelia Dallanoce, and Julia Bätz, and Jessica Klöckner, and Jens Schmitz, and Carlo Matera, and Katharina Simon, and Anna Kebig, and Lucas Peters, and Anke Müller, and Jasmin Schrobang-Ley, and Christian Tränkle, and Carsten Hoffmann, and Marco De Amici, and Ulrike Holzgrabe, and Evi Kostenis, and Klaus Mohr
July 2000, Molecular vision,
Andreas Bock, and Nicole Merten, and Ramona Schrage, and Clelia Dallanoce, and Julia Bätz, and Jessica Klöckner, and Jens Schmitz, and Carlo Matera, and Katharina Simon, and Anna Kebig, and Lucas Peters, and Anke Müller, and Jasmin Schrobang-Ley, and Christian Tränkle, and Carsten Hoffmann, and Marco De Amici, and Ulrike Holzgrabe, and Evi Kostenis, and Klaus Mohr
January 2010, Pharmacology,
Copied contents to your clipboard!